GeneDx Holdings Corp.

WGS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$8$11-$7$5
Dep. & Amort.$6$6$6-$6
Deferred Tax$0-$0$0-$0
Stock-Based Comp.$11$8$4$3
Change in WC-$3-$16$3-$8
Other Non-Cash$9$2$3$2
Operating Cash Flow$16$10$10-$3
Investing Activities
PP&E Inv.-$6-$2-$6-$3
Net Acquisitions$0$0$0$0
Inv. Purchases-$6-$14-$17-$14
Inv. Sales/Matur.$7$13$14$16
Other Inv. Act.$0-$33$0$0
Investing Cash Flow-$5-$36-$9-$1
Financing Activities
Debt Repay.-$1-$1-$1$2
Stock Issued$12$1$15$32
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$3
Financing Cash Flow$11$0$14$31
Forex Effect$0$0$0$0
Net Chg. in Cash$22-$26$14$27
Supplemental Information
Beg. Cash$75$101$86$59
End Cash$97$75$101$86
Free Cash Flow$10$8$4-$6